Rave Lite For Phase IV Trials

Designed for post-marketing surveillance and observational studies, Medidata’s Rave EDC offers a tailored and scalable solution for Phase IV and late-stage trials. Key features include integration with eConsent and eCOA for seamless patient collaboration, real-time data validation, and efficient reuse of Electronic Health Record (EHR) data to reduce site burden.

Rave’s interoperability and intelligent coding capabilities simplify data entry and review, enabling quick access to insights through advanced dashboards and reporting tools. Leveraging advanced tools like Medidata Link, Rave connects clinical trial data to real-world insights, driving informed decisions and optimizing the success of late-stage trials.